African Palliative Care Journal | 26 October 2008
Design and Implementation of an Anti-VEGF Eye Drop Delivery System for Diabetic Retinopathy in Rural Mozambique Over Two Years
N, d, e, y, e, F, a, t, o, u, T, o, u, r, é, M, a, c, a, r, t, h, y
Abstract
Diabetic retinopathy is a common complication of diabetes that can lead to vision loss in rural Mozambique where access to specialized care is limited. A longitudinal study involving 200 participants who received a novel anti-VEGF eye drop regimen. Data collection included visual acuity tests and patient-reported outcomes at baseline, six months, and one year post-intervention. Visual acuity improved by an average of 15% in the first year with no significant adverse effects reported among participants. The anti-VEGF eye drop system showed promise for improving diabetic retinopathy outcomes in rural Mozambique, though further research is needed to validate these findings. Continue monitoring long-term efficacy and explore integration into existing healthcare systems. Engage with local communities to ensure patient compliance and sustainability of the programme. Diabetic Retinopathy, Anti-VEGF Eye Drops, Rural Mozambique, Longitudinal Study Treatment effect was estimated with $\text{logit}(p<em>i)=\beta</em>0+\beta^\top X_i$, and uncertainty reported using confidence-interval based inference.